Neurology & Pain Research

Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathy (DPN) affects millions of individuals living with diabetes, causing nerve damage that can lead to pain, numbness, tingling, and reduced mobility. CenExel partners with sponsors to advance innovative therapies designed to improve symptom management, nerve function, and overall quality of life for patients living with DPN.

Studies Conducted
0 +
Trial Participants
0 +
Active Centers
0
Overview

Advancing Research in Diabetic Peripheral Neuropathy

CenExel specializes in clinical research focused on diabetic nerve pain and neuropathic disorders. Our experienced investigators and operational teams support sponsors through every stage of the clinical trial process — from early-phase studies to large-scale multicenter trials.

We are committed to accelerating treatment innovation while ensuring patient safety, scientific accuracy, and high-quality data collection.

Conditions Covered

Diabetic Neuropathy Conditions Covered

Our research programs support a broad range of diabetic neuropathy and nerve-related conditions, including:

  • Diabetic Peripheral Neuropathy (DPN)
  • Painful Diabetic Neuropathy (PDN)
  • Small Fiber Neuropathy
  • Chronic Nerve Pain
  • Peripheral Nerve Damage
  • Diabetic Foot Pain
  • Sensory Neuropathy
  • Autonomic Neuropathy
Our Approach

Trusted Clinical Research for DPN Studies

CenExel provides scientific expertise, patient recruitment capabilities, and operational excellence to support successful diabetic neuropathy clinical trials.

01

Experienced Neurology Investigators

Dedicated specialists with extensive experience in diabetic neuropathy and chronic pain research.

02

Advanced Patient Recruitment

Access to diverse patient populations across multiple U.S. research sites.

03

Biomarker & Endpoint Strategy

Support for validated pain assessments, neurological testing, and efficacy endpoints.

04

Efficient Trial Execution

Optimized workflows and centralized coordination to improve enrollment and study performance.

Phase Coverage

Clinical Trial Phases We Support

CenExel supports diabetic peripheral neuropathy studies across all major phases:

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Our teams provide support for proof-of-concept studies, long-term safety evaluations, and post-marketing research programs.

Let’s Advance Your Next Study

Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.

Explore Our Network

Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.

Our Blog